Having been a shareholder since the stock listed I have seen these spikes in sales and price regularly over the years......and while the volumes are a bit higher than the formative years, they are really not large. As much as I believe that GSS is still very much under valued......I don't imagine a lot will change until FDA approval comes through......and we can only hope that happens sooner rather than later and it results in some big players showing real interest.
News: GSS Genetic Signatures Expects Sales Of At Least A$21M For Half Year, page-29
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
-0.010(1.32%) |
Mkt cap ! $169.9M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 76.0¢ | 75.0¢ | $1.304K | 1.738K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 74.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 3399 | 1 |
View Market Depth
| Last trade - 14.33pm 26/07/2024 (20 minute delay) ? |
| GSS (ASX) Chart |